Advertisement
Canada markets open in 49 minutes
  • S&P/TSX

    21,587.88
    -51.22 (-0.24%)
     
  • S&P 500

    5,473.23
    +41.63 (+0.77%)
     
  • DOW

    38,778.10
    +188.94 (+0.49%)
     
  • CAD/USD

    0.7283
    -0.0006 (-0.08%)
     
  • CRUDE OIL

    80.36
    +0.03 (+0.04%)
     
  • Bitcoin CAD

    89,453.12
    -574.60 (-0.64%)
     
  • CMC Crypto 200

    1,352.50
    -36.90 (-2.66%)
     
  • GOLD FUTURES

    2,331.90
    +2.90 (+0.12%)
     
  • RUSSELL 2000

    2,022.01
    +15.85 (+0.79%)
     
  • 10-Yr Bond

    4.2850
    +0.0060 (+0.14%)
     
  • NASDAQ futures

    19,964.50
    +43.25 (+0.22%)
     
  • VOLATILITY

    12.67
    -0.08 (-0.63%)
     
  • FTSE

    8,186.35
    +44.20 (+0.54%)
     
  • NIKKEI 225

    38,482.11
    +379.67 (+1.00%)
     
  • CAD/EUR

    0.6784
    -0.0003 (-0.04%)
     

Redwire Breaks Ground on New State-of-the-Art Microgravity Payload Development and Space Operations Facility in Floyd County, IN

JACKSONVILLE, Fla., June 05, 2024--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that it has officially broken ground on the company’s 30,000 square foot state-of-the-art microgravity payload development and space operations facility at the Novaparke Innovation & Technology Campus in Floyd County, Indiana. Redwire executives were joined by Representative Erin Houchin, state and local government officials, and academic leaders from Indiana University Southeast for a groundbreaking ceremony on May 31.

"Redwire’s investment in this state-of-the-art facility will enable our company to meet the growing demand for in-space research and manufacturing," said John Vellinger, Redwire’s President of In-Space Industries. "Our recent on-orbit successes with human tissue bioprinting and novel pharmaceutical crystal formation are revolutionary and are building strong demand for our products. The additional laboratories will help us increase our throughput on Earth and in space."

The new facility will support Redwire’s cutting edge space biotechnology programs that are making it possible for the biopharma industry to achieve game-changing outcomes not possible on Earth. One such capability is bioprinting three-dimensional structures, a crucial step toward printing tissues and organs for transplant and research. Redwire recently announced the successful bioprinting of live human heart tissue on its 3D BioFabrication Facility (BFF) on the International Space Station (ISS). Another biopharma-related breakthrough is the ability to grow large and highly ordered crystals for pharmaceutical use. On the same flight that returned heart tissue samples, Redwire received a batch of space-flown crystal experiments from its Pharmaceutical In-space Laboratory (PIL-BOX) platform. Redwire has 16 in-space investigations planned for PIL-BOX.

ADVERTISEMENT

BFF and PIL-BOX are part of Redwire’s expansive array of space biotech and microgravity development platforms that make use of the space environment to improve life on Earth. Redwire has developed 20 research facilities for crewed spacecraft, with 10 currently aboard the ISS supporting world-leading research and manufacturing missions.

About Redwire

Redwire Corporation (NYSE:RDW) is a global space infrastructure and innovation company enabling civil, commercial, and national security programs. Redwire’s proven and reliable capabilities include avionics, sensors, power solutions, critical structures, mechanisms, radio frequency systems, platforms, missions, and microgravity payloads. Redwire combines decades of flight heritage and proven experience with an agile and innovative culture. Redwire’s approximately 700 employees working from 14 facilities located throughout the United States and Europe are committed to building a bold future in space for humanity, pushing the envelope of discovery and science while creating a better world on Earth. For more information, please visit redwirespace.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240605116603/en/

Contacts

Media Contact:
Emily Devine
Emily.Devine@redwirespace.com
305-632-9137

OR

Investors:
investorrelations@redwirespace.com
904-425-1431